The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
to 35 cents from 40 cents previously as he sees slower revenue momentum based on the company’s 3QFY2024 ended Sept 30 update. Hyphens Pharma reported 3QFY2024 revenue of $43.9 million, 2.5% higher y-o ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...